{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:40:44Z","timestamp":1775014844934,"version":"3.50.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natinal hospital organaization","award":["H29-NHO-01"],"award-info":[{"award-number":["H29-NHO-01"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma (HCC). The aim of the present study was to determine whether circulating soluble TIM3 (sTIM3) is elevated in patients with AIH patients and whether sTIM-3 levels are associated with clinical parameters of AIH.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We enrolled 123 Japanese patients with AIH who were identified from the National Hospital Organization\u2013AIH-liver\u2013network database, as well as 32 patients with chronic hepatitis C (CHC), 30 patients with primary biliary cholangitis (PBC) and healthy control subjects. Serum sTIM-3 concentrations were quantified by ELISA.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Serum levels of sTIM-3 were significantly higher in AIH patients (median 4865 pg\/ml; [interquartile range (IQR); 3122\u20137471]) compared to those in CHC (1026 pg\/ml [IQR: 806\u20131283] <jats:italic>p<\/jats:italic>&lt;0.001), PBC (2395 pg\/ml [IQR: 2012\u20133422] <jats:italic>p<\/jats:italic>&lt;0.001) or healthy controls (1285 pg\/ml [IQR: 1098\u20131812] <jats:italic>p<\/jats:italic>&lt;0.001). In AIH group, serum sTIM-3 were correlated with alanine aminotransferase (ALT), or total bilirubin (TB) and negatively correlated with serum levels of albumin (Alb). Serum levels of sTIM-3 were also strongly correlated with Mac-2 binding protein glycosylation isomer (M2BPGi) levels, but did not correlate with the histological grade of liver fibrosis. Steroid treatment of AIH patients significantly reduced serum sTIM-3 levels (2147\u00b1623pg\/ml versus 1321\u00b1378pg\/ml, <jats:italic>p<\/jats:italic>&lt;0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Circulating sTIM-3 levels were elevated in AIH patients and are associated with AIH disease activity and AIH-related liver damage. These findings indicate that serum sTIM-3 correlated with disease status of AIH and could be useful biomarkers to detect autoimmune-mediated liver injury. Our data suggest a possible link between the TIM-3\/GAL-9 pathway and AIH severity or phenotype, and further investigations of the TIM-3 pathway and AIH pathophysiology is warranted.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0238540","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T18:50:02Z","timestamp":1608576602000},"page":"e0238540","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-5622","authenticated-orcid":true,"given":"Kiyoshi","family":"Migita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Kozuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Abiru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsumasa","family":"Komori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junpei","family":"Temmoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaname","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Ario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Mannami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Kaneyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Komura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yatsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,12,21]]},"reference":[{"key":"pone.0238540.ref001","first-page":"449","article-title":"Tim-3: an activation marker and activation limiter of innate immune cells","volume":"4","author":"G Han","year":"2013","journal-title":"Front Immunol"},{"issue":"8","key":"pone.0238540.ref002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.it.2011.05.003","article-title":"Emerging Tim-3 functions in anti-microbial and tumor immunity","volume":"32","author":"K Sakuishi","year":"2011","journal-title":"Trends Immunol"},{"key":"pone.0238540.ref003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000282066","article-title":"Adaptive immunity in autoimmune hepatitis","volume":"28","author":"MS Longhi","year":"2010","journal-title":"Dig Dis"},{"key":"pone.0238540.ref004","first-page":"e12825","article-title":"TIM-3: An Emerging Target in the Liver Diseases","volume":"4","author":"L Zhao","year":"2019","journal-title":"Scand J Immunol"},{"issue":"1","key":"pone.0238540.ref005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molimm.2013.11.001","article-title":"The Tim-3\/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis","volume":"58","author":"Y Ju","year":"2014","journal-title":"Mol Immunol"},{"issue":"2","key":"pone.0238540.ref006","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"R Liberal","year":"2012","journal-title":"Hepatology"},{"issue":"48","key":"pone.0238540.ref007","doi-asserted-by":"crossref","first-page":"34529","DOI":"10.1074\/jbc.M113.488478","article-title":"A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3)","volume":"288","author":"K M\u00f6ller-Hackbarth","year":"2013","journal-title":"J Biol Chem"},{"key":"pone.0238540.ref008","doi-asserted-by":"crossref","first-page":"168","DOI":"10.12659\/MSMBR.910949","article-title":"Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus","volume":"24","author":"L Jin","year":"2018","journal-title":"Med Sci Monit Basic Res"},{"issue":"5","key":"pone.0238540.ref009","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1478-3231.2011.02734.x","article-title":"Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study)","volume":"32","author":"K Migita","year":"2012","journal-title":"Liver Int"},{"key":"pone.0238540.ref010","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"F Alvarez","year":"1999","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0238540.ref011","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"VJ Desmet","year":"1994","journal-title":"Hepatology"},{"issue":"5","key":"pone.0238540.ref012","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.27305","article-title":"Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients","volume":"60","author":"K Yamasaki","year":"2014","journal-title":"Hepatology"},{"issue":"9902","key":"pone.0238540.ref013","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"MA Heneghan","year":"2013","journal-title":"Lancet"},{"key":"pone.0238540.ref014","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"A Floreani","year":"2018","journal-title":"J Autoimmun"},{"issue":"2","key":"pone.0238540.ref015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"YS de Boer","year":"2014","journal-title":"Gastroenterology"},{"issue":"10","key":"pone.0238540.ref016","doi-asserted-by":"crossref","first-page":"e0187325","DOI":"10.1371\/journal.pone.0187325","article-title":"HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4\/DR8 heterozygous genotype","volume":"12","author":"S Oka","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0238540.ref017","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"34","author":"MS Longhi","year":"2010","journal-title":"J Autoimmun"},{"key":"pone.0238540.ref018","doi-asserted-by":"crossref","first-page":"101302","DOI":"10.1016\/j.smim.2019.101302","article-title":"Tim-3: A co-receptor with diverse roles in T cell exhaustion and tolerance","volume":"42","author":"R Tang","year":"2019","journal-title":"Semin Immunol"},{"key":"pone.0238540.ref019","first-page":"1","article-title":"TIM-3 and its regulatory role in immune responses","volume":"350","author":"C Zhu","year":"2011","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"pone.0238540.ref020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"C Zhu","year":"2005","journal-title":"Nat Immunol"},{"issue":"35","key":"pone.0238540.ref021","doi-asserted-by":"crossref","first-page":"e16924","DOI":"10.1097\/MD.0000000000016924","article-title":"Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis","volume":"98","author":"N Matsuoka","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"pone.0238540.ref022","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fimmu.2012.00047","article-title":"The role of coinhibitory signaling pathways in transplantation and tolerance","volume":"3","author":"MM McGrath","year":"2012","journal-title":"Front Immunol"},{"issue":"1","key":"pone.0238540.ref023","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"Tim-3 and its role in regulating anti-tumor immunity","volume":"276","author":"M Das","year":"2017","journal-title":"Immunol Rev"},{"issue":"6","key":"pone.0238540.ref024","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.coi.2006.09.009","article-title":"TIM-3 in autoimmunity","volume":"18","author":"AC Anderson","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"pone.0238540.ref025","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/hep.29307","article-title":"Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis\/autoimmune sclerosing cholangitis","volume":"66","author":"R Liberal","year":"2017","journal-title":"Hepatology"},{"key":"pone.0238540.ref026","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13000-015-0306-0","article-title":"Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus","volume":"10","author":"LJ Song","year":"2015","journal-title":"Diagn Pathol"},{"key":"pone.0238540.ref027","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.40399","article-title":"Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis","volume":"70","author":"M Fleury","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"pone.0238540.ref028","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4049\/jimmunol.176.3.1411","article-title":"Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response","volume":"176","author":"H Geng","year":"2006","journal-title":"J Immunol"},{"issue":"9","key":"pone.0238540.ref029","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/eji.200939274","article-title":"TIM-3 Is Expressed on Activated Human CD4+ T Cells and Regulates Th1 and Th17 Cytokines","volume":"39","author":"WD Hastings","year":"2009","journal-title":"Eur J Immunol"},{"key":"pone.0238540.ref030","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection","volume":"205","author":"RB Jones","year":"2008","journal-title":"J Exp Med"},{"issue":"7","key":"pone.0238540.ref031","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/jgh.13708","article-title":"Hepatic stellate cells secreting WFA+ -M2BP: Its role in biological interactions with Kupffer cells","volume":"32","author":"Y Bekki","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"pone.0238540.ref032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2017.07.016","article-title":"Check point inhibitors as therapies for infectious diseases","volume":"48","author":"MA Cox","year":"2017","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"pone.0238540.ref033","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clim.2015.03.008","article-title":"Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3","volume":"158","author":"L Golden-Mason","year":"2015","journal-title":"Clin Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T18:50:27Z","timestamp":1608576627000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238540"}},"subtitle":[],"editor":[{"given":"Yun-Wen","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,21]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238540","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,21]]}}}